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ABSTRACT
microRNAs (miRNAs) spatio-temporally modulate
gene expression; however, very little is known
about the regulation of their expression. Here, we
hypothesized that the well-known cis-regulatory
elements of gene expression, scaffold/matrix-
attachment regions (MARs) could modulate miRNA
expression. Accordingly, we found MARs to be
enriched in the upstream regions of miRNA
genes. To determine their role in cell type-specific
expression of miRNAs, we examined four individual
miRNAs (let-7b, miR-17, miR-93 and miR-221) and
the miR-17–92 cluster, known to be overexpressed
in neuroblastoma. Our results show that MARs
indeed define the cell-specific expression of these
miRNAs by tethering the chromatin to nuclear
matrix. This is brought about by cell type-specific
binding of HMG I/Y protein to MARs that then
promotes the local acetylation of histones, serving
as boundary elements for gene activation. The
binding, chromatin tethering and gene activation
by HMG I/Y was not observed in fibroblast control
cells but were restricted to neuroblastoma cells.
This study implies that the association of MAR
binding proteins to MARs could dictate the tissue/
context specific regulation of miRNA genes by
serving as a boundary element signaling the
transcriptional activation.
INTRODUCTION
The importance of nuclear architecture in governing
transcription of genes/gene clusters in the genome is
well established. This is achieved at multiple levels by
(i) making distinct territories of chromosomes (1) and
(ii) further compartmentalization of genes into distinct
domains by periodic looping of chromatin, called as
scaffold/matrix-attachment regions (S/MARs) (2,3).
MARs tether the chromatin to the base of nuclear
matrix, where transcription factories are present and
poise the chromatin for transcription (4,5). Previous
studies have demonstrated the importance of these
cis-acting elements in viral integration, locus control of
gene clusters in a spatio-temporal manner, promoting
or inhibiting transcription of individual genes in a
context-dependent manner (4,6–10). Regions of the
genome attach to the nuclear scaffold/matrix in both
a cell type- and cell cycle context-speciﬁc manner,
although the precise mechanism(s) are yet unknown. It
has been estimated that approximately 64000S/MARs
divide the somatic genome into a series of 100kb
domains, with each domain bound by a S/MAR at each
end. However, only a subset of potential S/MARs may be
active in a cell at any given time. Changes in the activity of
these sites may provide a means to modulate phenotype
(11). This can be partly attributed to the binding of
speciﬁc transcription factors/chromatin modiﬁers to
these regions in the genome, thereby imparting gene
regulatory function. It is, therefore, not surprising that
changes in the nature of these MAR binding proteins
(MARBPs) often lead to malignancies (12). Several
studies have highlighted the importance of MARBPs
like SATB1, SMAR1, NMP, SAF-A and other
non-conserved AT hook region binding proteins like
HMG family members in gene regulation and cancer
(13–17). However, a categorical binding site
representation has not been elucidated due to the
non-conserved nature of these MAR sites. It is
postulated that these MARBPs are crucial to the
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elements like S/MARs.
Since their discovery, microRNAs (miRNAs) have
generated immense interest as modulators of gene
expression in a tissue and organ-speciﬁc manner (18–21).
A number of studies have been and are being pursued
to understand their biogenesis and functions in regulating
cell lineage commitment and disease manifestation.
Since miRNAs complimentarily bind to their target
mRNAs thereby interfering with translation and/or
inducing degradation of target mRNAs, their activation
can lead to inactivation of many target genes and hence
pathways. Studies on miRNA-expression proﬁles of
human tumors have identiﬁed signatures associated
with diagnosis, staging, progression, prognosis and
response to treatment (22–24). Recent reports also
suggest complex interactions of miRNAs with the
machinery that controls the transcriptome, concurrently
targeting multiple mRNAs (24). Hence, understanding
the regulation of expression of these miRNAs in normal
and transformed tissues/cells is paramount, as this
would provide fundamental insights into cancer cell
reprogramming.
In this study, we hypothesized that cis-acting MAR
elements would regulate the tissue and cell type-speciﬁc
expression of miRNAs. We show that MARs are
enriched in the upstream regions of miRNA genes
(encoding primary transcript) and they spatially restrict
the activation of miRNA genes as well as miRNA gene
clusters. Further, using neuroblastoma cells and primary
ﬁbroblasts, we show that MARs can deﬁne the tissue/
cell-speciﬁc expression of miRNAs augmenting or
blocking their transcription. This regulation is governed
by binding of a speciﬁc MAR binding protein HMG I/Y,
a chromatin modulator.
MATERIALS AND METHODS
In silico prediction of MARs
MARs have been predicted to occur in every 10kb in the
mammalian genome (25,26). Thus, sequences spanning
miRNA genes and a 10kb upstream region were down-
loaded for all human miRNAs obtained from miRBase
14.0 and checked for the presence of conserved MAR
(peak cut off=0.5) using MARWiz (27). The conserved
positions were marked and the window of the high MAR
potential recorded.
Cell lines and transfections
The human neuroblastoma IMR-32 cells and mouse
embryonic ﬁbroblasts (MEFs) were cultured in RPMI
and DMEM medium, respectively, supplemented with
10% FBS, L-glutamine and Pencillin–Streptomycin and
maintained in a 5% CO2 humidiﬁed chamber at 37C.
Different concentrations of HMG I/Y siRNA were trans-
fected using SureFECT transfection reagent (Qiagen) in
IMR-32 cells for 72h and evaluated for cell death, or
processed for RT–PCR. Cell death was assessed by
trypan blue exclusion assay.
PCR ampliﬁcation and cloning
Regions surrounding the high MAR potential were
ampliﬁed from IMR-32 genomic DNA using primers for
the following miRNA-MARs:
let-7b F: AGATTTCCCTGCGTGTGAAG (Ta=51)
let-7b R: AGGAGAGGCATTGACGAAGA
miR-221 F: GGGCAGGGTTTGTTTCTAGG (Ta=51)
miR-221 R: TCAATGGAATTGCAACACAAA
miR-17 F (US1): GGGCACATTATACGTGCTTG
(Ta=51)
miR-17 R (US1): AAAACCTAGTCATGCCACCA
miR-93 F: TTCCAACAACTCTGCCATTTT (Ta=51)
miR-93 R: TGTGCTGGGACAACTGGATA
miR-17–92 cluster US2 F: TGGCATTGGCTCTTTGAT
CAGCA(Ta=56)
miR-17–92 cluster US2 R: TGCAAAAGTCCTGCATG
GTTTGGT
All the experiments were performed using limiting cycles
of PCR.
Matrix–loop partitioning assay
Nuclear matrix- and loop-associated pools of genomic
DNA were prepared as previously described (28), with
minor modiﬁcations. Brieﬂy, IMR-32 and MEF cells
were washed with phosphate buffer followed by sequential
lysis with CSK-1 (0.5% Triton X-100, 10mM PIPES at pH
6.8, 100mM NaCl, 300mM sucrose, 3mM MgCl2,1m M
EGTA, 1mM PMSF and 1x protease inhibitor cocktail)
and CSK-2 buffers (same as CSK-1 except that Triton
X-100 is omitted). DNase1was added and digestion was
performed for 1h. Digested supernatant (loop DNA), as
well as pellet containing undigested material (nuclear
matrix+MARs), were collected independently and DNA
was puriﬁedbyproteinase K digestion followed byphenol–
chloroform extraction and ethanol precipitation. Isolated
pools of matrix- or loop-associated DNA were used as
templates for PCR ampliﬁcation with different sets of
primers designed for the miR-17–92 cluster and individual
miRNAs. PCR products were resolved by agarose gel elec-
trophoresis, stained with Ethidium bromide (Molecular
Probes) and visualized by UV transillumination.
MAR binding assay
Nuclear matrix isolated from IMR-32 or MEF cells was
suspended in 90ml MAR binding buffer (20mM Tris–HCl
pH 7.4, 50mM NaCl, 2mM EDTA, 0.25M Sucrose
and 0.25mg/ml BSA). Sheared salmon sperm DNA
(100mg/ml) and 5ng/ml (50000cpm) biotin-labeled
DNA fragments from MAR region of miRNAs were
mixed and incubated with nuclear matrix fraction at
25C for 4h with constant gentle shaking. Reaction
mixture was diluted with 1ml binding buffer, centrifuged
and the matrix-bound fragments were solubilized in 0.5%
SDS. The soluble mixture was treated with 0.5mg/ml
proteinase K for 5h, phenol–chloroform extracted,
ethanol precipitated and ﬁnally resolved on an 8% poly-
acrylamide–0.1% SDS gel and documented with chemilu-
minescence assay kit (Pierce).
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For the Chromatin immunoprecipitation (ChIP) assay,
1–510
6 cells were treated with DMEM containing 1%
formaldehyde for 10min at 37C for cross-linking, which
was stopped by a 10min incubation with 1.5M glycine.
After washing twice, the cells were resuspended in 300ml
of SDS lysis buffer [50 mM Tris–HCl (pH 8.0), 10mM
EDTA, 1% SDS and protease inhibitors] by pipetting
and kept on ice for 20min. The chromatin was then
sonicated into fragments with an average length of
0.3–7kb. After centrifugation at 13000rpm for 10min,
the supernatants were diluted with dilution buffer
[50mM Tris–HCl (pH 8.0), 1.1% NP-40, 167mM NaCl
and protease inhibitors]. The extracts were pre-cleared by
incubation with 30ml of protein G-Sepharose beads
(Amersham Biosciences) for 6h. The supernatants were
mixed with antibodies for 16h and incubated with
protein G-Sepharose beads for 3h. The incubated beads
were then washed once with low-salt buffer [50mM Tris–
HCl (pH 8.0), 2mM EDTA, 2% NP-40 and 0.2% SDS]
containing 150mM NaCl, once with high-salt buffer con-
taining 500mM NaCl and once with LiCl wash solution
[10 mM Tris–HCl (pH 8.0), 250mM LiCl, 1mM EDTA
and 0.5% NP-40]. The washed beads were incubated in
elution buffer [10 mM Tris–HCl (pH 8.0), 300mM NaCl,
5mM EDTA and 0.5% SDS] at 65C for 12h, followed by
phenol–chloroform treatment and ethanol precipitation.
ChIP DNA was ampliﬁed by standard PCR using Taq
polymerase with the primers from Cybergene, as listed.
The following antibodies were used: anti-HMG I/Y,
anti-AcH3K9/14 (Santa Cruz), anti-H3K9 tri methyl
(Abcam) and rabbit or mouse immunoglobins (Bio-Rad).
RESULTS
miRNA genes are ﬂanked by MARs
The organization of chromatin into topologically
constrained loops serves to deﬁne functional genetic
domains. Such loops are thought to be established by
S/MARs. MARs have been identiﬁed at the boundaries
of functional transcription units from several species and
they have been shown to buffer effects of ﬂanking
chromatin. However, whether MARs can buffer miRNA
expression is unknown. A recent study showed that the
upstream MARs serve as enhancers augmenting transcrip-
tion while intra/intergenic MARs could function as
transcription inhibiting structures (29).
To identify if MARs were present upstream of and/or
within miRNA genes, we examined the sequence spanning
miRNA genes and a 10kb region upstream using
MARWiz. After ﬁltering with high stringency parameters
(peak threshold=1), we found that 436 of 452 miRNAs
considered here, possessed conserved upstream MAR
elements, with 38% miRNAs possessing more than
Figure 1. Properties of MARs predicted upstream of miRNAs. (A) Number of MAR elements predicted upstream of miRNAs. MARs were
observed in the upstream regions of vast majority (96%) of miRNA genes. (B) Distance of predicted MARS from miRNA genes. MARs were
predicted at distances as short as 610bp to 9.5kb upstream of the miRNA genes. (C) DNA strand speciﬁcity of miRNAs and predicted MARs.
miRNAs on both positive and negative strands have similar frequency of upstream MARs. (D) Intronic and intergenic miRNA genes have
similar frequency of upstream MARs.
6910 Nucleic Acids Research, 2011,Vol.39, No. 16one MAR element (Figure 1A). MAR elements were
found distributed across10 kb region upstream of
miRNA genes, analyzed here. However, no MARs were
detected within or encompassing the miRNA genes
(Figure 1B). There were no signiﬁcant differences in the
presence of MAR elements among miRNAs coded by
negative or positive DNA strands (Figure 1C) or in the
intronic or intergenic miRNAs (Figure 1D). These obser-
vations imply that presence of an upstream MAR element
is a conserved feature for miRNA coding genes. This led
us to examine the functional consequence of the presence
of these upstream MARs in regulating the miRNA
expression.
The miRNA–MARs partition genes to active fronts
As MARs can regulate the tissue expressivity based on
its tethering to nuclear matrix, we aimed to investigate
the possible correlation between the cell type-speciﬁc
expression of miRNAs to the presence of MARs. For
this, we identiﬁed and characterized MARs from the
miRNAs overexpressed in neuroblastoma and compared
them to primary MEFs (Figure 2A). These include
miR-221, let-7b, miR-17 and miR-93. All these miRNAs
possessed MARs, however, at varying distances from the
miRNA genes (Supplementary Figure S1). We then tested
the functional activity of these MARs by checking their
afﬁnity to isolated nuclear matrix from IMR-32 cell line.
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Figure 2. MAR partitioning and expression of miRNAs. (A) Real-time PCR analysis showing the relative expression of indicated miRNAs in
IMR-32 neuroblastoma cells and MEFs normalized to 5s rRNA levels. The values are mean±SD from three independent experiments. **Indicates
P<0.01. (B) Immunoblot analysis for nuclear matrix (NM)-speciﬁc lamin B and chromatin-speciﬁc histone 1 (H1) in each of the fractions to rule out
cross contamination. (C) Ampliﬁcation of the speciﬁc MAR element from each of the represented miRNAs from genomic DNA of IMR-32 cells. (D)
MAR binding assay employing NM from IMR-32 cells and the biotin-labeled individual MAR elements as probe. PCR ampliﬁcation of the
individual MAR elements in the chromatin (Chr) or NM fractions of IMR-32 neuroblastoma cells (E) or mouse embryonic ﬁbroblasts (MEFs)
(F). The graphs in (G) and (H) depict the relative amount of MAR amplicons in NM and chromatin fractions of IMR-32 and MEF cells respectively,
drawn of densitometric analysis from 3 independent experiments. Statistical comparisons were done using Students t-test. *Indicates P<0.05 and
**P<0.01.
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and chromatin fractions. Cross-contamination of each
of the fractions was ruled out by use of Lamin B and
histone 1 antibody (Figure 2B). MAR binding assays
showed that all the MARs (ampliﬁed as single products
from genomic DNA of IMR-32 cells, Figure 2C)
bound to the nuclear matrix with equal propensity
(Figure 2D). In vivo partitioning assays also revealed
a strong association of these MARs with the nuclear
matrix and not with the chromatin fraction in these cells
(Figure 2E).
Since MARs are known to be cell type-speciﬁc and
at a given point in any cell type only a subset of MARs
bind to nuclear matrix and partition chromatin into
distinct domains based on the genes to be transcribed,
we checked if this partitioning was intact in MEFs.
We observed that the MAR elements are ampliﬁed in
the chromatin fraction and do not partition discretely
into the nuclear matrix (Figure 2F). This is, in contrast
to IMR-32 cells, where a distinct partitioning to nuclear
matrix was observed. This was demonstrated by a rela-
tive partitioning analysis, where the amplicons were
quantitated and compared in the nuclear matrix and
chromatin fractions in IMR-32 and MEF cells, respective-
ly (Figure 2G and H). By employing luciferase reporter
assays, we found that the MARs upstream of miRNAs
can augment the transcription, as has been previously
observed for MARs upstream of protein coding genes
(8,12) (Supplementary Figure S2). A luciferase vector
hosting an extended region ﬂanking the MARs excluding
the core 200bp MAR sequence served to negate random
sequence activity, if any.
MARs as small range locus control regions for miRNA
clusters
MARs are known to be insulators or enhancers for gene
loci. In this case, we sought to check if a single MAR is
sufﬁcient to regulate the expression of all the miRNAs in
a miRNA cluster. For this, we checked for the presence
of MARs in the miR-17–92 cluster, containing 6 miRNAs
namely miR-17, 18a, 19a, 20a, 19b1 and miR-92a1, all
of which are expressed in neuroblastoma (Figure 3A).
The 10kb region ﬂanking this miRNA cluster comprised
of two conserved MARs-one upstream (depicted as US1)
and one downstream (DS). Genomic PCR conﬁrmed the
ampliﬁcation of the whole sequence cluster as individual
segments (Figure 3B). We chose a non-MAR containing
region 1kb upstream of the US1 site (depicted as US2)
and used this as control for elucidating MAR speciﬁc
functions.
Next, we checked the partitioning of these miRNA
genes into active matrix and chromatin loops and found
that the MARs and the genes in the miR-17–92 cluster
associated preferentially to nuclear matrix in IMR-32
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Figure 3. MARs inﬂuence miRNA clusters. (A) Schematic representation of miRNA 17–92 cluster and the ﬂanking 10kb regions. The dark boxes
represent conserved MAR elements (US1 and DS), boxes in white the individual miRNA genes and the shaded box a control region upstream of the
MAR element (US2). The graph below depicts the MAR potential of the individual MAR element present upstream and downstream of the miRNA
17–92 cluster, with the arrows pointing the region of maximum peak potential. (B) Ampliﬁcation of the MAR elements and the individual miRNA
genes from the genomic DNA of IMR-32 cells.
6912 Nucleic Acids Research, 2011,Vol.39, No. 16cells, while in MEFs they were found to be associated with
the chromatin fraction (Figure 4A).
The binding of MARBPs to MARs is critical for the
regulatory role of these cis-acting elements, constituting
a cis-element–trans-factor interplay. Therefore, we
sought to identify the common factors that could poten-
tially bind to all these MARs. For this, we performed
binding site analysis of transcription factors in these
MAR elements using ConSite (30). Interestingly, all the
sequences showed atleast one high potential (80%
cut-off) HMG I/Y protein binding site (Figure 4B).
Also, HMG I/Y is an AT hook binding protein and is
overexpressed upon malignant transformations (15).
Immunoblot analysis showed that the expression of
HMG I/Y protein in MEF cells was 2.4-fold lesser
compared to IMR-32 cells (Figure 4C). This was reﬂected
in our ChIP experiments where HMG I/Y speciﬁcally
bound to the US1 MAR sequence in IMR-32 cells while
the binding was negligible in MEF cells. Interestingly, the
downstream MAR did not show any binding (Figure 4D).
Rabbit immunoglobin and US2 served as negative
controls. Similar to our observations for the miR-17–92
cluster MAR, we found that the individual MARs
upstream of miRs let 7b, 93 and 221 showed strong
binding to HMG I/Y in IMR-32 cells and not in MEFs
(Figure 4E).
Since HMG I/Y proteins are minor groove AT hook
binding proteins and are documented to be chromatin
modulators, we checked the nature of chromatin in these
sequences. In case of miR-17–92 cluster, all the individual
miRNA genes were acetylated at histones H3 at lysine
9 and 14 positions (Figure 5A). The MAR sequences,
both upstream and downstream, were also found to be
acetylated at histone 3 in the same positions. US2 did
not show any enrichment of acetylated histones, suggest-
ing that hyperacetylated MARs may act as boundaries
between chromatin in the expressed and non-expressed
states (Figure 5A). However, in case of MEFs, the
MARs were not enriched in acetylated histones, rather
they were tri-methylated at histone lysine 9 position
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Figure 4. Factor binding and MAR partitioning. (A) NM and Chr from IMR-32 cells and MEFs were fractionated and checked for ampliﬁcation of
the individual genes and the MAR elements of the miRNA 17–92 cluster. (B) Schematic representation of the putative HMG I/Y binding sites
(represented by arrows) in the MAR regions (black box) of the individual miRNA genes and the miRNA 17–92 cluster (gray boxes). The distance of
MARs from the each miRNA gene is also provided. (C) Immunoblot analysis of HMG I/Y in 50mg of total lysates from MEFs and IMR-32 cells.
Tubulin was used as loading control. (D) Chromatin immunoprecipitate from IMR-32 (I) or MEFs (M) were analyzed for binding of HMG I/Y
protein to the upstream or downstream MAR region from miRNA 17–92 cluster. Rabbit immunoglobin served as negative control (IgG). A quantity
of 10% of the total lysate was used as input (Inp). (E) HMG I/Y binding to the individual MAR elements of miRNAs 17, 93, 221 and let-7b
was checked in MEFs and IMR-32 cells.
Nucleic Acids Research, 2011,Vol.39, No. 16 6913indicating a closed chromatin conformation (Figure 5B,
lower panel). Individual MAR elements also displayed
this effect where we could observe hyperacetylation
marks in the MAR regions in IMR-32 cells (Figure 5C).
Taken together, these results suggest the involvement of
HMG I/Y in binding to the MARs of the miRNA genes
and promoting an open chromatin conformation
facilitating the miRNA gene transcription.
HMG I/Y affects miRNA expression
To further test, if the knockdown of HMG I/Y results in
altered expression of the corresponding miRNA genes,
we performed knockdown studies in IMR-32 cells.
Interestingly, upon transfection of HMG I/Y siRNA
in neuroblastoma cells most of the cells lost viability
after 72h of transfection. This time point coincides with
60–70% knockdown of HMG I/Y protein (Figure 6A
and B). To address this, we opted for a time point
when most of the cells were still viable but exhibited
only a 30–40% knockdown. Under these conditions, the
expression levels of individual miRNAs were quantiﬁed
and we identiﬁed that HMG I/Y knockdown signiﬁcantly
reduced the expression of all the miRNAs, studied here
(Figure 6C). Additionally, the partitioning of the MAR
regions of these individual miRNAs at 48h of knockdown
was altered and we observed MARs both in the chromatin
and nuclear matrix fractions even in limiting cycles of
PCR (Figure 6D). Therefore, the increased cell death
observed upon 60–70% knockdown might be a result of
the down regulation of these anti apoptotic miRNA genes.
These results demonstrate the crucial role of HMG I/Y in
tethering the MARs to nuclear matrix, whereby miRNA
gene expression is regulated.
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Figure 5. MARs are active chromatin regions. (A) Chromatin from IMR-32 and MEFs were extracted and immunoprecipitated with acetylated
histone 3 lysine 9/14. The immunoprecipitates were then analyzed for ampliﬁcation of miR-17–92 cluster and the upstream and downstream MAR
elements. Rabbit IgG served as negative control. Equal amounts of starting material were used, as veriﬁed using 10% total lysate as input. (B)
Chromatin immunoprecipitates from IMR-32 and MEF cells were analyzed for histone 3 lys 9 trimethylation (H3K9 me3) or acetylation (H3K9/14
Ac) of the upstream and downstream MARs (US1 and DS) and control element (US2) to verify the epigenetic status of these regions. (C) Chromatin
immunoprecipitate from IMR-32 cells were analyzed for the histone acetylation status of the MAR elements for the indicated miRNAs. A quantity
of 10% of total lysate served as input. Pre-immune sera served as negative control.
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This study presents evidence for miRNA gene regulation
in a tissue/cell type-speciﬁc manner by cis-acting matrix-
attachment regions. We have shown that the majority of
the miRNA genes are ﬂanked by at least one MAR
element upstream of miRNA genes. This appears to be a
conserved feature since the coding strand or the gene dis-
tribution with respect to protein coding genes (inter/
intragenic) appears to have no bearing on the distribution
of MARs upstream of miRNA genes. Further studies on
MARs in promoters beyond 10kb upstream of miRNA
genes might provide additional insights into cis-regulatory
roles of MARs. Also, we observed 96% of miRNA genes
were predicted to contain MARs in the downstream
region. This might represent potentiation of chromatin
loop formation ﬂanking the gene(s).
Models of DNA replication associated with the nuclear
matrix have proposed that the replicon clusters
correspond to the 50–200kb repeating MARs that are
attached to the nuclear matrix (31–34). As a basic unit,
the loop is essential for DNA replication, transcription
regulation and chromosomal packaging (35–37).
Moreover, these MARs are dynamic and can vary from
cell type to cell type, conferring another layer of
spatio-temporal gene regulation. Here, we demonstrate
the dependence of expression pattern of miRNA(s) and
AD
B
CE
Figure 6. HMG I/Y regulates the miRNA gene partitioning. (A) Immunoblot analysis for HMG I/Y after partial knockdown using 100 and 200nM
siRNA, compared with siRNA control (Ctrl) and untreated cells, after 72h and 48h of transfection. Tubulin was used as loading control.
(B) Quantiﬁcation of cell death by trypan blue exclusion assay by transfection of HMG I/Y using 100nM or 200nM siRNA or Ctrl in IMR-32
cells after 72h. Results are means of three independent experiments±SD. (C) Quantitation of the levels of the indicated miRNAs in untreated cells
IMR-32 cells (Unt) and after 48h of siRNA mediated HMG I/Y knockdown (HMG I/Y si) using real-time RT–PCR analysis. The expression levels
were normalized using 5s rRNA as internal control. A control siRNA (Ctrl si) was used as negative control. Statistical comparisons were done using
Students t-test. *indicates P<0.05, **P<0.01, ***P<0.001. (D) The NM and chromatin fractions from IMR-32 untreated control cells or HMG
I/Y siRNA transfected cells were used to amplify the miRNA 17-92 gene cluster (panel above) and the MAR elements of indicated miRNAs (panel
below). (E) Schematic representation of cis-regulation of miRNA expression by NM–loop organization in target and non-target tissues. In the target
tissue (left panel) transcription is facilitated by attachment of MARs to the NM by speciﬁc MARBPs like HMG I/Y. This regulates expression by
bringing the miRNA genes to the close proximity of transcription factories containing RNA polymerase and other components of the transcription
apparatus. In non-target tissues/cells, MARs ﬂanking the genes are not bound to the matrix due to absence of speciﬁc MARBPs preventing the gene/
locus from associating with the focal points of high transcriptional activity.
Nucleic Acids Research, 2011,Vol.39, No. 16 6915miRNA cluster on the association of upstream MARs
with nuclear matrix. We used IMR-32 neuroblastoma
cells as model to investigate some of the well-known
oncomiRs including the miR-17–92 cluster. We show
that the each of these miRNAs and the cluster possesses
a MAR at different positions in the upstream regions
(Supplementary Figure S1) and all these MAR elements
can augment the transcriptional activity of these miRNA
genes. Moreover, in neuroblastoma cells, these regions are
strongly bound to the nuclear matrix. In primary ﬁbro-
blasts, where the expression of the examined miRNAs was
signiﬁcantly reduced, MARs were associated with the
chromatin. Also, the transcriptional activity of these
MAR elements were signiﬁcantly lesser in ﬁbroblasts
than in IMR-32 cells, suggesting the possible involvement
of other factors in cell type-speciﬁc transcriptional
augmentation.
It is widely believed that the biological signiﬁcance and
its behavior relies on determining the physical attributes of
in vivo S/MARs and their association with speciﬁc
proteins that bind to it. Though S/MARs function as
the mediators of loop attachment, they are used in a
selective and dynamic fashion. Also, while they are neces-
sary they alone are not sufﬁcient for chromatin loop
formation (38). Nevertheless, their role in transcriptional
regulation of genes and gene clusters is well appreciated.
This transcriptional regulation is achieved by binding
of epigenetic regulators that are ubiquitous and/or
tissue-speciﬁc transcription factors including special
(A+T)-rich binding protein 1 (SATB1), nuclear matrix
protein 4 (NMP4) or CTCF (39). These proteins may
promote the assembly of complex nucleoprotein supra-
molecular structures, as exempliﬁed by the cage-like
structures formed by SATB1, which circumscribe hetero-
chromatic portions of chromosomes while allowing eu-
chromatic sequences to loop out in the nucleus.
MAR binding proteins may also recruit histone acetyl-
transferases and ATP-dependent chromatin remodeling
complexes, thereby increasing gene expression (40).
Thus, MAR elements may delimit chromosomal regula-
tory domains and recruit proteins that control the local
chromatin structure.
Considering this option, we checked the putative tran-
scription factor binding sites in all the individual MAR
elements and identiﬁed HMG I/Y as the most likely
MARBP. The HMG I/Y family of ‘high mobility group’
non-histone proteins consists of architectural transcrip-
tion factors whose overexpression is highly correlated
with both cancerous transformation and increased
malignancy and metastatic potential of tumors in vivo.I t
is well documented that HMG I/Y regulates long-range,
enhancer-dependent transcription on DNA and chroma-
tin by changes in DNA topology (41).
We validated the HMG I/Y binding to the MAR sites
of miRNA genes by use of ChIP. In case of miR-17–92
cluster, though the cluster was ﬂanked on either side by
MAR regions, HMG I/Y preferably bound to the
upstream MAR. The binding of HMG I/Y was signiﬁ-
cantly less (almost negligible) in ﬁbroblasts, which might
be attributed to the lesser protein or cell type-speciﬁc
post-translational modiﬁcation. We believe that the cell
type speciﬁcity might be conferred by proteins like
HMG I/Y that recognize substrate structure, rather than
nucleotide sequence and preferentially binds to distorted
DNA structures. This would be then followed by
a multiprotein assembly on DNA, forming a transcription
enhancer code, deﬁning cell type speciﬁcity. Since the
MAR regions are generally enriched for transcription
factor binding, it would be interesting to check the other
conserved non MAR binding factor sites that lie in close
proximity. For instance, we found that although Sox-5
and N-Myc are not classiﬁed as MAR binding proteins,
their binding sites were juxtaposed to HMG I/Y binding
sites in MAR elements.
In most instances, chromatin exerts a repressive effect
and if either nucleosomes or inhibitory chromatin proteins
(such as histone H1) are associated with important
regulatory regions, gene transcription is attenuated or
shut off. Several studies have shown that the binding to
S/MARs by HMG-A promotes the establishment of an
‘open’ or accessible chromatin domain structure that is
permissive for transcription to occur (42–44). Moreover
these types of AT hook containing proteins play
a central role in nucleosome remodeling complexes like
RSC in Saccharomyces cerevisiae and SWI/SNF in
humans (45,46). In this study, we found that the binding
of HMG I/Y promotes an open chromatin conformation
by hyperacetylating histones, favoring the transcription of
miRNA genes. In ﬁbroblasts we observed trimethylation
at the histone 3 lysine 9 at the MAR loci, indicative of
silenced chromatin. This was correlated to low expression
levels of miRNA genes.
Since HMG I/Y can alter the topology of DNA we
hypothesized that the knockdown of this protein by
siRNA would affect the partitioning of MARs to the
nuclear matrix fraction. With the near complete HMG
I/Y knockdowns being lethal, we investigated partial
knockdowns and found that even a 30–40% knockdown
was sufﬁcient to disrupt the discrete segregation of
miRNA MARs to the nuclear matrix. Under these condi-
tions, the expression levels of the miRNAs were also
drastically reduced. Thus taken together these suggest
that the binding of HMG I/Y to the MARs is crucial to
their tethering to the nuclear matrix, which in turn
inﬂuences the expression levels of miRNA(s).
Our studies for the ﬁrst time have addressed the inter-
play between cis-acting MAR elements and miRNA gene
expression as a function of cell/tissue type MAR binding
proteins (Figure 6E). Therefore, the cell and context type
speciﬁcity of miRNAs appear to involve a coordinated
activity of cis-regulation, transcription factor binding,
and chromatin modulation culminating in speciﬁc gene
expression. Further understanding of this cell type-speciﬁc
MARs and binding factors could provide valuable
insights into the regulation of oncomirs and their
networks.
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